Description

Rinomistin (Xylometazoline, Miramistin) Nasal Drops Solution 0,05%/0,01% 10 ml Vial

Ingredients

Rinomistin nasal drops contain xylometazoline (0.05%) and miramistin (0.01%) as active ingredients. Xylometazoline is a decongestant that works by constricting blood vessels in the nasal passages, reducing swelling and congestion. Miramistin is an antiseptic that helps prevent bacterial and viral infections in the nasal cavity.

Dosage

The recommended dosage for Rinomistin nasal drops is usually 1-2 drops in each nostril, 2-3 times a day. It is important not to exceed the recommended dosage to avoid potential side effects.

Indications

Rinomistin nasal drops are indicated for the relief of nasal congestion due to colds, allergies, or sinusitis. The combination of xylometazoline and miramistin helps to clear nasal passages and reduce inflammation, allowing for easier breathing.

Contraindications

Do not use Rinomistin nasal drops if you are allergic to any of the ingredients, have high blood pressure, heart disease, or diabetes without consulting a healthcare professional. Avoid using the drops for more than 7 consecutive days to prevent rebound congestion.

Directions

To use Rinomistin nasal drops, tilt your head back slightly, insert the dropper into the nostril, and squeeze the bulb to release the drops. Breathe in gently and repeat the process for the other nostril. Avoid blowing your nose immediately after using the drops to allow for better absorption.

Scientific Evidence

Studies have shown that xylometazoline, the active decongestant in Rinomistin nasal drops, effectively reduces nasal congestion by constricting blood vessels in the nasal passages. Miramistin, the antiseptic component, helps prevent secondary infections, providing a dual-action approach to nasal congestion relief.

Additional Information

It is important to store Rinomistin nasal drops at room temperature and away from direct sunlight. Keep the vial tightly closed when not in use to prevent contamination. If symptoms persist after using the drops for the recommended duration, consult a healthcare professional for further evaluation.

Pharmacologically, xylometazoline acts on alpha-adrenergic receptors in the nasal mucosa, leading to vasoconstriction and decreased nasal blood flow, which helps reduce congestion. Miramistin, on the other hand, exhibits broad-spectrum antimicrobial activity, making it effective in preventing nasal infections.

Clinical trials have demonstrated the efficacy of Rinomistin nasal drops in providing rapid relief from nasal congestion with minimal side effects. Compared to other nasal decongestants, Rinomistin’s combination of xylometazoline and miramistin offers a comprehensive solution for nasal congestion and associated symptoms.